NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 02/14/2025 | 254.00 K | $304.80 K | 640.95% | 1.41% |
| MORGAN STANLEY | 02/14/2025 | 102.58 K | $123.10 K | 100.00% | 0.57% |
| JANE STREET GROUP, LLC | 02/14/2025 | 64.64 K | $77.56 K | 100.00% | 0.36% |
| HRT FINANCIAL LP | 02/14/2025 | 64.39 K | $77.00 K | 100.00% | 0.36% |
| XTX TOPCO LTD | 02/13/2025 | 41.90 K | $50.28 K | -8.91% | 0.23% |
| MEITAV INVESTMENT HOUSE LTD | 02/03/2025 | 40.00 K | $48.00 K | 0.00% | 0.22% |
| STRATOS WEALTH PARTNERS, LTD. | 01/27/2025 | 20.00 K | $24.00 K | 100.00% | 0.11% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 16.25 K | $20.00 K | 28.71% | 0.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 15.87 K | $19.04 K | 32.66% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 15.02 K | $18.02 K | 100.00% | 0.08% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2025 | 10.70 K | $12.84 K | 100.00% | 0.06% |
| CWM, LLC | 02/04/2025 | 1.00 K | $1.00 K | 0.00% | 0.01% |
| 02/06/2025 | 175 | $210 | 100.00% | 0.00% | |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NeuroSense Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 12 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
Stratos Wealth Partners, LTD.: 0
CITADEL ADVISORS LLC: 253,997
MORGAN STANLEY: 102,581
JANE STREET GROUP, LLC: 64,636
HRT FINANCIAL LP: 64,390
XTX Topco Ltd: 41,897
3.58% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 625.34 K shares in the last 24 months. This purchase volume represents approximately $675.37 K in transactions.